The Centers for Disease Control and Prevention have CDC and Bree Collaborative have revised Opioid Prescribing Guidelines that include best practice recommendations for acute, subacute and chronic opioid use. The updated and expanded guidelines support WSHA’s aims to ensure equitable access to effective, informed, individualized and safe pain care.
CMOs, pharmacists and opioid stewardship committees can register here to join WSHA in an overview of and discussion on implementing best practices to support opioid safety across all ages in our communities.
“The science on pain care has advanced over the past six years,” said Debbie Dowell, MD, MPH, chief clinical research officer for CDC’s Division of Overdose Prevention. “During this time, CDC has also learned more from people living with pain, their caregivers and their clinicians. We’ve been able to improve and expand our recommendations by incorporating new data with a better understanding of people’s lived experiences and the challenges they face when managing pain and pain care.”
The CDC will continue to work to improve patient safety and outcomes by equipping health care professionals and patients with data, tools and guidance they need to make informed treatment decisions. The 2022 Clinical Practice Guideline supports patients and clinicians working together to make informed, individualized decisions about safe and effective pain care. See CDC Releases UPDATED Clinical Practice Guideline for Prescribing Opioids for Pain for more information. (Tina Seery)
